A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.

The nonclinical pharmacokinetic (PK) and pharmacodynamic (PD) study was conducted to examine the effects of semaglutide ...

Announcing a new article publication for BIO Integration journal. Diabetes, a common metabolic condition, poses a substantial health burden worldwide. To revolutionize diabetes management, enhance ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

This can lead to stomach problems and pain. Diabetes is a chronic condition in which the body either doesn’t make enough insulin (a hormone that allows cells to take in glucose from the blood) or ...

Insulin is a hormone produced by the pancreas that helps cells ... even though their blood sugar levels are more likely to skew high than low. Glucagon kits, widely used to treat hypoglycemia in type ...

Traditionally, blood sugar regulation has been attributed to the hormones insulin and glucagon, both produced by the pancreas. Insulin lowers blood glucose by promoting its uptake into cells ...

However, if this increase in blood sugar isn't matched with an equivalent decrease in insulin production (the hormone responsible for facilitating glucose uptake), it can lead to elevated blood sugar ...

and a new study into genetically altered beta cell therapy tested in type 1 diabetes. We are aware of reports regarding supply issues of insulin in the UK. Some of these reports are of insuli ...

Injectable glucagon can treat severely low levels ... They can also teach you how to appropriately dose and time your insulin. Low blood sugar, or hypoglycemia, is common in people with type ...

Glucagon is a hormone produced by α cells in the pancreas. It works alongside insulin to regulate blood sugar levels, raising them when they drop too low. However, in people with type 2 diabetes ...